April 28, 2020 / 9:29 PM / a month ago

BRIEF-Crispr Therapeutics Reports First Quarter 2020 Financial Results

April 28 (Reuters) - CRISPR Therapeutics AG:

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* CRISPR THERAPEUTICS AG - CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2020, WERE $889.7 MILLION

* CRISPR THERAPEUTICS AG QTRLY TOTAL COLLABORATION REVENUE WAS $0.2 MILLION VERSUS $0.3 MILLION

* CRISPR THERAPEUTICS AG QTRLY BASIC LOSS PER SHARE $1.15)

* CRISPR THERAPEUTICS AG - ENROLLMENT ONGOING IN CLINICAL TRIALS OF CTX001 FOR PATIENTS WITH SEVERE HEMOGLOBINOPATHIES

* CRISPR THERAPEUTICS AG - ENROLLMENT ONGOING IN CLINICAL TRIAL OF CTX110, TARGETING CD19+ MALIGNANCIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below